A Phase (Ph) Ii Study Of The Efficacy And Safety Of The Cmet Inhibitor Capmatinib (Inc280) In Patients (Pts) With Advanced Hepatocellular Carcinoma (Hcc)Tawesak Tanwandee,Wattana Sukeepaisarnjaroen,Stephen L. Chan,SuPin Choo,Guohong Han,Virote Sriuranpong,Hongming Pan,Thomas Cheung Yau,Zhenggang Ren,Jianming Xu,Bin Peng, Takami Saji,Yongjian Sun,Alan Huang,Luigi Manenti,Shukui QinJOURNAL OF CLINICAL ONCOLOGY（2016）引用 7|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
